Fraxiparine (Nadroparin Calcium)

Fraxiparine is a medication containing Nadroparin Calcium, used for anticoagulation therapy. It is administered intravenously and is manufactured by Mylan Healthcare B.V. in the EU.

Fraxiparine is primarily used for anticoagulation, which helps prevent blood clots. It is often prescribed for conditions where blood clotting needs to be managed, such as during certain medical procedures or for patients at risk of thromboembolism. The medication works by inhibiting the formation of clots in the blood vessels, ensuring smooth blood flow.

Common effects of Fraxiparine may include bruising or bleeding at the injection site. Some users might experience mild pain or swelling. These effects are generally temporary and should be monitored. If any severe reactions occur, medical attention should be sought immediately.

Fraxiparine should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of infection or other complications. Patients with a history of bleeding disorders or allergies to similar medications should consult their healthcare provider before use.

Fraxiparine may interact with other anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be avoided as it can increase the risk of bleeding. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.